Oncotelic Therapeutics, Inc. (OTLC) stock
OTLCOTCPharmaceutical PreparationsFiscal year ends December 31
$0.02+0.00 (+11.45%)
Close on Oct 19, 2026Market cap $8.66MP/E 0.0Yield –
Oncotelic Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Oncotelic Therapeutics's total assets was $394.75M at Jun 30, 2026. For fiscal 2025 it was $393.09M, up 1373.5% from the year before. Over ten years it grew 30.5% a year on average. The highest annual figure on record is $393.09M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $393.09M | +1373.5% |
| FY2024 | Dec 31, 2024 | $26.68M | -11.1% |
| FY2023 | Dec 31, 2023 | $30.01M | -16.9% |
| FY2022 | Dec 31, 2022 | $36.12M | +53.0% |
| FY2021 | Dec 31, 2021 | $23.61M | -0.2% |
| FY2020 | Dec 31, 2020 | $23.66M | -0.1% |
| FY2019 | Dec 31, 2019 | $23.68M | +762.0% |
| FY2018 | Dec 31, 2018 | $2.75M | +134.5% |
| FY2017 | Dec 31, 2017 | $1.17M | -91.7% |
| FY2016 | Dec 31, 2016 | $14.11M | -48.6% |
| FY2015 | Dec 31, 2015 | $27.45M | -9.8% |
| FY2014 | Dec 31, 2014 | $30.42M | +317.1% |
| FY2013 | Dec 31, 2013 | $7.29M | +33.9% |
| FY2012 | Dec 31, 2012 | $5.45M | -50.7% |
| FY2011 | Dec 31, 2011 | $11.06M | +98.6% |
| FY2010 | Dec 31, 2010 | $5.57M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $394.75M | +1380.2% |
| Q1 FY2026 | Mar 31, 2026 | $393.96M | +1376.7% |
| Q4 FY2025 | Dec 31, 2025 | $393.09M | +1367.7% |
| Q2 FY2025 | Jun 30, 2025 | $26.68M | -10.9% |
| Q1 FY2025 | Mar 31, 2025 | $26.67M | -11.0% |
| Q4 FY2024 | Dec 31, 2024 | $26.68M | -11.1% |
| Q3 FY2024 | Sep 30, 2024 | $26.78M | -11.0% |
| Q2 FY2024 | Jun 30, 2024 | $29.94M | -0.3% |
| Q1 FY2024 | Mar 31, 2024 | $29.97M | -16.8% |
| Q4 FY2023 | Dec 31, 2023 | $30.01M | -16.9% |
| Q3 FY2023 | Sep 30, 2023 | $30.10M | -25.2% |
| Q2 FY2023 | Jun 30, 2023 | $30.01M | -25.7% |
| Q1 FY2023 | Mar 31, 2023 | $36.05M | +55.8% |
| Q4 FY2022 | Dec 31, 2022 | $36.12M | +53.0% |
| Q3 FY2022 | Sep 30, 2022 | $40.24M | +73.5% |
| Q2 FY2022 | Jun 30, 2022 | $40.39M | +70.3% |
| Q1 FY2022 | Mar 31, 2022 | $23.13M | -3.6% |
| Q4 FY2021 | Dec 31, 2021 | $23.61M | -0.2% |
| Q3 FY2021 | Sep 30, 2021 | $23.19M | -5.8% |
| Q2 FY2021 | Jun 30, 2021 | $23.71M | -1.3% |
| Q1 FY2021 | Mar 31, 2021 | $23.99M | +1.7% |
| Q4 FY2020 | Dec 31, 2020 | $23.66M | -0.1% |
| Q3 FY2020 | Sep 30, 2020 | $24.63M | +227.1% |
| Q2 FY2020 | Jun 30, 2020 | $24.01M | +213.5% |
| Q1 FY2020 | Mar 31, 2020 | $23.60M | +5934.9% |
| Q4 FY2019 | Dec 31, 2019 | $23.68M | +762.0% |
| Q3 FY2019 | Sep 30, 2019 | $7.53M | +555.2% |
| Q2 FY2019 | Jun 30, 2019 | $7.66M | +264.9% |
| Q1 FY2019 | Mar 31, 2019 | $391.00K | -10.5% |
| Q4 FY2018 | Dec 31, 2018 | $2.75M | +134.5% |
| Q3 FY2018 | Sep 30, 2018 | $1.15M | -61.4% |
| Q2 FY2018 | Jun 30, 2018 | $2.10M | -67.9% |
| Q1 FY2018 | Mar 31, 2018 | $437.00K | -95.7% |
| Q4 FY2017 | Dec 31, 2017 | $1.17M | -91.7% |
| Q3 FY2017 | Sep 30, 2017 | $2.98M | -82.8% |
| Q2 FY2017 | Jun 30, 2017 | $6.53M | -68.0% |
| Q1 FY2017 | Mar 31, 2017 | $10.18M | – |
| Q4 FY2016 | Dec 31, 2016 | $14.11M | – |
| Q3 FY2016 | Sep 30, 2016 | $17.26M | – |
| Q2 FY2016 | Jun 30, 2016 | $20.43M | – |
See a number that looks wrong?